TSX:CTX • CA2258471028
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CRESCITA THERAPEUTICS INC (CTX.CA).
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 23.53M 40.31% | 17.522M -25.53% | 19.58M 11.75% | |
| EBITDA YoY % growth | 2M 544.44% | -450K -122.50% | -1.849M -310.89% | |
| EBIT YoY % growth | 530K 128.96% | -1.956M -469.06% | -3.215M -64.37% | |
| Operating Margin | 2.25% | -11.16% | -16.42% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
CRESCITA THERAPEUTICS INC (CTX.CA) will report earnings on 2026-03-25.